First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?

First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?

The development of antiangiogenic treatments, followed by immune checkpoint inhibitors (ICI), has significantly changed the management of metastatic clear cell renal cell cancer. Several phase III trials show the superiority of combination therapy, dual immunotherapy (ICI-ICI) or ICI plus tyrosine k...

Full description

Bibliographic Details
Main Authors: Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, Slimane Dermeche, Jean-Christophe Eymard, Sabrina Falkowski, Marine Gross-Goupil, Gabriel Malouf, Bérangère Narciso, Christophe Sajous, Sophie Tartas, Eric Voog, Alain Ravaud
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cancers
Subjects:
metastatic clear cell renal cell carcinoma
first-line treatment
immunotherapy
tyrosine kinase inhibitors
combinations
Online Access:https://www.mdpi.com/2072-6694/13/21/5548

Internet

https://www.mdpi.com/2072-6694/13/21/5548

Similar Items